Article Information
History
- October 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Joeri Smits, PhD1,2,†,
- Amyn A. Malik, MBBS, MPH, PhD3,4,†,
- Jad A. Elharake, MPH,3,4,
- Ahmed Mushfiq Mobarak, PhD,5,6,7 and
- Saad B. Omer, MBBS, MPH, PhD, FIDSA,3,4,8,9,*
- 1Harvard Kennedy School, Cambridge, MA, USA 02138
- 2Harvard Institute for Quantitative Social Science, Cambridge, MA, USA 02138
- 3Yale Institute for Global Health, New Haven, CT, USA 06510
- 4Yale School of Medicine, New Haven, CT, USA, 06510
- 5Yale School of Management, New Haven, CT, USA. 06511
- 6Yale Department of Economics, New Haven, CT, USA 06511
- 7Deakin University, Burwood, VIC, Australia 3125
- 8Yale School of Public Health, New Haven, CT, USA 06510
- 9Yale School of Nursing, Orange, CT, USA 06477
- ↵*Correspondence to:
Saad B. Omer; 1 Church Street, New Haven, CT 06510; saad.omer{at}yale.edu; 443-983-1396
↵† Authors contributed equally
Posted October 21, 2022.
Did Risk-based or Age-based Vaccine Prioritization for Covid-19 Save More Lives?
